| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|
Spinocerebellar ataxia panel: SCA1, SCA2, SCA3, SCA6 and SCA7 (detetion of CAG expansion on ATXN1, ATXN2, ATXN3, CACNA1A and ATXN7 genes) CGC Genetics Unilabs
Portugal | 1 | 5 | - T Targeted variant analysis
|
Spinocerebellar ataxia panel: SCA8, SCA10, SCA12 and SCA17 (detetion of expansion on ATXN8OS/ATXN8, ATXN10, PPP2R2B and TBP genes) CGC Genetics Unilabs
Portugal | 1 | 4 | - T Targeted variant analysis
|
Spinocerebellar ataxia panel: SCA1, SCA2, SCA3, SCA6, SCA7, SCA8, SCA10, SCA12, SCA17 and Dentatorubral-pallidoluysian atrophy (DRPLA) CGC Genetics Unilabs
Portugal | 1 | 10 | - T Targeted variant analysis
|
IMPORTANT NOTE: NIH does not independently verify information submitted to
the GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute
for medical advice. Patients and consumers with specific questions
about a genetic test should contact a health care provider or a genetics professional.
